Janus kinase/signal transducer and activator of transcription pathway in schizophrenia (Review)
Emmanouil Rizos1, Christos Theleritis1, James N Tsoporis2
1Second Department of Psychiatry, Attikon University General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Abstract:
Schizophrenia is a complex mental disorder that affects cognition, emotions and behaviour. Among the signaling pathways that show dysregulation in schizophrenia is the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway. JAK/STAT is a pleiotropic pathway that plays key roles in multiple cellular functions. A brief overview of dysregulated signaling in schizophrenia is provided in the present review, focusing on the JAK/STAT pathway. Depending on the disease stage, dysregulation of signaling pathways causes inflammation, which is a key factor in the onset and maintenance of schizophrenia. The dysregulated JAK/STAT signaling pathway is implicated in schizophrenia through numerous processes, including neuro- and gliogenesis, synaptic plasticity and microglia activation. Research on JAK/STAT pathway components can contribute to knowledge that will be translated into efficient therapeutic management strategies to improve the quality of life of patients with schizophrenia.
Insights
This review explores the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway
Area of Science:
- Neuroscience
- Molecular Biology
- Psychiatry
Background:
- Schizophrenia is a complex mental disorder impacting cognition, emotion, and behavior.
- The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is frequently dysregulated in schizophrenia.
- Inflammation, driven by signaling pathway dysregulation, is crucial in schizophrenia's onset and progression.
Purpose of the Study:
- To provide an overview of dysregulated signaling in schizophrenia.
- To focus on the role of the JAK/STAT pathway in schizophrenia.
- To highlight the potential of JAK/STAT research for therapeutic strategies.
Main Methods:
- Literature review of studies on signaling pathways in schizophrenia.
- Focus on research detailing JAK/STAT pathway involvement.
- Analysis of the link between JAK/STAT dysregulation and schizophrenia pathophysiology.
Main Results:
- The JAK/STAT pathway is implicated in key processes like neurogenesis, gliogenesis, synaptic plasticity, and microglia activation in schizophrenia.
- Dysregulation of this pathway contributes to inflammation, a critical factor in the disorder.
- Evidence suggests a multifaceted role for JAK/STAT signaling in the complex mechanisms of schizophrenia.
Conclusions:
- The JAK/STAT pathway is a significant player in schizophrenia pathogenesis.
- Understanding JAK/STAT dysregulation offers insights into schizophrenia's inflammatory and cellular processes.
- Targeting JAK/STAT components may lead to novel therapeutic interventions for schizophrenia.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
cAMP-dependent Protein Kinase Pathways
MAPK Signaling Cascades
